Bristol Myers Squibb CEO describes new drug for treating schizophrenia
January 13, 2025 at 18:44 PM EST
Bristol Myers Squibb CEO Chris Boerner described Cobenefy, a new drug to treat schizophrenia and may also help with bipolar disorder and Alzheimer's disease.